EssilorLuxottica acquires Optegra clinics with support from MidEuropa

The acquisition will enable Optegra and EssilorLuxottica to expand into new areas of medical technology. Image credit: ©New Africa – stock.adobe.com

In a press release, medtech company EssilorLuxottica announced its acquisition of European ophthalmic clinic network Optegra Eye Health Care, supported by investment firm MidEuropa. Pending regulatory approvals and other closing procedures, the transaction is expected to be finalised in 2025. Optegra currently operates clinics in five European markets: the United Kingdom, the Czech Republic, Poland, Slovakia and the Netherlands.

Per the press release, the Optegra group operates over 70 care facilities across its key markets, under the brand names Iris and Lexum as well as its ubiquitous Optegra label. The Optegra platform will expand EssilorLuxottica’s medical technology strategy and portfolio. Optegra clinics offer both medically necessary ophthalmic interventions and elective vision correction, including cataract and refractive surgery, lens exchange, glaucoma treatments and therapies for age-related macular degeneration.¹ The acquisition announcement highlighted opportunities for EssilorLuxottica and Optegra to put innovations such as wearable lens technologies and artificial intelligence (AI) into practice.

Peter Byloos, MD, CEO of Optegra said joining forces with EssilorLuxottica will begin a “transformative chapter” for the clinics’ practitioners and patients. “[EssilorLuxottica’s] global leadership in vision care, combined with our clinical excellence and patient-centric approach, creates an innovative platform to redefine the paradigm of ophthalmic services,” he commented. “This partnership not only accelerates our growth potential but also enhances our ability to deliver advanced, digital and integrated eyecare solutions to all our patients.”

EssilorLuxottica’s Francesco Milleri, CEO and chairman, and Paul du Saillant, deputy CEO, said in a joint statement that the acquisition will expand the companies’ capabilities in next-generation tech. “We have the strategic assets to fuel this vision: an extensive distribution network with new clinical approaches, a smart eyewear offering with healthcare potential and diagnostic capabilities that will be able to detect conditions ranging from neurodegenerative diseases to cardiovascular dysfunction,” the leaders stated. “Powered by our growing AI and big data capabilities, we will be able to broaden our impact and deliver the most personalised and seamless patient journey.”

Reference

1. EssilorLuxottica to acquire Optegra clinics, another leap forward in its med-tech strategy. Press release. EssilorLuxottica. Published May 30, 2025. Accessed May 30, 2025. https://ml-eu.globenewswire.com/media/d33d6b3b-a208-495d-a666-b79e359622b4/document/?v=05292025035900